Hyflux has disputed Salim-Medco’s assertion that actions by PUB and offtakers or buyers of water from its Magtaa desalination plant in Algeria constitute events which allow the Indonesian group to pull out from its proposed S$530 million investment into the troubled water treatment company.
Caption: 
Hyflux has disputed Salim-Medco’s assertion that actions by PUB and offtakers or buyers of water from its Magtaa desalination plant in Algeria constitute events which allow the Indonesian group to pull out from its proposed S$530 million investment into the troubled water treatment company.